Solstein Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 314 |
|
|
2023
Q4 | – | Sell |
-157
| Closed | -$9.11K | – | 309 |
|
|
2023
Q3 | $9.11K | Hold |
157
| – | – | 0.01% | 235 |
|
|
2023
Q2 | $10K | Buy |
+157
| New | +$10K | 0.01% | 231 |
|
|
2022
Q4 | – | Sell |
-1,240
| Closed | -$88K | – | 289 |
|
|
2022
Q3 | $88K | Hold |
1,240
| – | – | 0.08% | 121 |
|
|
2022
Q2 | $95K | Hold |
1,240
| – | – | 0.07% | 138 |
|
|
2022
Q1 | $91K | Hold |
1,240
| – | – | 0.06% | 153 |
|
|
2021
Q4 | $77K | Sell |
1,240
-450
| -27% | -$27.9K | 0.05% | 182 |
|
|
2021
Q3 | $100K | Hold |
1,690
| – | – | 0.06% | 171 |
|
|
2021
Q2 | $113K | Buy |
1,690
+450
| +36% | +$30.1K | 0.14% | 151 |
|
|
2021
Q1 | $78K | Buy |
+1,240
| New | +$78K | 0.11% | 168 |
|
|
2020
Q4 | – | Sell |
-1,240
| Closed | -$75K | – | 100 |
|
|
2020
Q3 | $75K | Hold |
1,240
| – | – | 0.17% | 106 |
|
|
2020
Q2 | $73K | Hold |
1,240
| – | – | 0.17% | 91 |
|
|
2020
Q1 | $69K | Buy |
1,240
+444
| +56% | +$24.7K | 0.27% | 63 |
|
|
2019
Q4 | $51K | Buy |
+796
| New | +$51K | 0.1% | 109 |
|